Shares of Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) were up 0.2% during trading on Monday . The company traded as high as €26.02 and last traded at €25.72. Approximately 169,544 shares changed hands during mid-day trading, an increase of 80% from the average daily volume of 94,405 shares. The stock had previously closed at €25.68.
Carl Zeiss Meditec Stock Performance
The company has a market cap of $2.40 billion, a price-to-earnings ratio of 13.75, a P/E/G ratio of 2.83 and a beta of 1.41. The company has a current ratio of 2.35, a quick ratio of 2.47 and a debt-to-equity ratio of 28.70. The stock’s fifty day simple moving average is €25.47 and its 200 day simple moving average is €33.66.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
